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Abstract: 
Objective: To investigate the prevalence of neurogenic heterotopic ossification (NHO) in patients 
with traumatic brain injury (TBI) or traumatic spinal cord injury (TSCI) admitted to non-specialised 
units.  
Subjects and Method: Retrospective audit of patients, using the ICD-10-AM coding system, admitted 
to The Townsville Hospital (TTH) with TBI/TSCI between 1 July 2006 and 31 December 2012.  
Results: 58 patients with length of stay (LOS) ≥60 days were admitted to TTH with TBI/TSCI over this 
period; mean age 60 years (range 31-87 years); (55 were TBI and 3 TSCI patients). 3114 TBI/TSCI 
patients with LOS <60 days and mean age of 43 years (range 18-93years) were also identified (2903 
were TBI and 211 TSCI patients). Overall, none were diagnosed with NHO; six patients, identified by 
the ICD-AM-10 codes, diagnosed with heterotopic ossification (HO) did not have an associated 
TBI/TSCI.  
Conclusion: Findings of zero percent of NHO prevalence in TSCI/TBI patients admitted to the large 
tertiary referral hospital suggest that NHO may have been missed, possibly due to the TSCI/TBI ICD-
10-AM codes, not being specifically designed for documentation of the TBI/TSCI complications. If
NHO remains undiagnosed in non-specialised units due to the method of coding, it may increase 
functional limitation in already compromised individuals. 
Number of words in abstract: 200 
Key words: Brain Injury, Spinal Cord Injury, Traumatic, Neurogenic Heterotopic Ossification, ICD-10 
coding 
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Introduction: 
Heterotopic ossification (HO) is the atypical formation of mature lamellar bone within extraskeletal 
soft tissues where bone normally does not exist; neurogenic heterotopic ossification (NHO) is one 
particular form of HO, following traumatic spinal cord (TSCI) and traumatic brain (TBI) injuries (1, 2). 
NHO typically develops within four months post neurological insult with the peak incidence at 
approximately two months post-injury (3). It manifests itself clinically as severe pain, swelling, 
erythema, warmth and decreased range of movement (3, 4). Patients with NHO usually develop 
lesions around larger joints, the hip being the most common location, followed by the knees and 
elbows (5, 6). A single joint is affected in approximately 40% of patients; in another third, two joints 
are affected (5, 7). Following its initial clinical manifestation, NHO tends to increase in size over the 
next two to three months and is usually fully developed two years post neurological injury (1, 3, 8). 
As the bone becomes mature it can be seen on radiographs and can result in a variety of 
complications, including nerve impingement, joint ankylosis, complex regional pain syndrome, and 
soft tissue infection (9). The associated decline in range of motion (ROM) may greatly limit activities 
of daily living, such as positioning, transferring and maintenance of hygiene, thereby adversely 
affecting quality of life (4, 10-14). 
The prevalence of NHO in the TSCI and TBI patients admitted to specialised units is relatively well 
documented (1, 3-5, 16-18). Clinically significant NHO in TSCI patients has been previously 
determined to be between 10% and 53% (16); in the TBI population the prevalence of NHO 
has been reported as being between 10% and 20% (4, 9). No comparative epidemiological data of 
NHO prevalence, however, is available for health-care facilities that are not specialized in treating 
patients with neurological trauma. In order to address this deficiency of existing data, a 
retrospective audit over a six and a half year period was carried out at a large tertiary hospital in 
September 2013.  
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Materials and Methods: 
The study was approved by the Human Ethics Committees at The Townsville Hospital (TTH) and 
James Cook University (JCU), Australia; the protocols conformed to the Declaration of Helsinki. TTH 
is the only tertiary hospital in North Queensland, although not considered to be a specialised unit for 
TSCI and TBI patients (15). 
 
Identification of patients 
Patients were identified using the Hospital Based Corporate Information System (HBCIS) and 
Transition II (TII) tools. At TTH, HBCIS is used to record inpatient and outpatient activity, including 
revenue and clinical coding. Data relating to emergency department attendances, radiology, 
pharmacy and pathology are not included in HBCIS. TII is used to record data relating to inpatient 
activity and clinical coding, costing and acuity. All data were extracted using Crystal Reports 2008, 
which is a SAP Business Objects(c) (Australia)  application and were exported to the Microsoft Excel© 
2003 spreadsheet. 
Audit protocol 
Retrospective data were provided by the clinical information services of the Townsville Hospital and 
Health Service. These data included all patients with head or and spinal injuries, and/or heterotopic 
ossification (HO)/myositis ossificans (MO), aged 18 years or over at the time of admission and who 
were discharged from TTH between 1 July 2006 and 31 December 2012. The data were then 
searched for patients with ICD-10-AM codes indicating traumatic spinal cord injury (TSCI) or 
traumatic brain injury (TBI) with resultant injury to the nervous system. Demographic data relating 
to age, length of stay (LOS) and discharge destination were also noted. 
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Patient diagnoses for TSCI or TBI were further identified using the ICD-10AM codes for TSCI/TBI (S06, 
S09, S14, S24, S34, T09) and M61 for HO/MO. 
The data were then filtered to identify patients with a length of stay (LOS) < 60days and a LOS ≥60 
days, and not currently recorded on Townsville HBCIS database as being deceased. The selection 
criterion of 60 days for LOS was chosen as NHO rarely becomes clinically relevant earlier than two 
months post trauma (1, 3).  
Data were also extracted for any patients aged 18 years or over at the time of admission, with a 
diagnosis of HO or MO, using the data code M61 for HO/MO and who were discharged from TTH 
between 1 July 2006 and 31 December 2012. 
ICD-10-AM (International Statistical Classification of Diseases and Related Health Problems, Tenth 
Revision, Australian Modification) refers to the Australian modification of the World Health 
organization (WHO) ICD-10 base classification system. This version of ICD has been modified to serve 
particular Australian needs and to support the national collection of data relevant to the Australian 
population's health. It is mandatory in all Australian hospitals and is purported to permit and support 
the systematic recording, analysis, interpretation and comparison of morbidity data. ICD-10-AM is 
used to translate diseases and other health problems from words into an alphanumeric code, 
allowing for easy storage, retrieval and analysis of the data. ICD-10-AM has been regularly reviewed 
and updated since its first release and implementation in 1998. 
Clinical coding is undertaken by trained coders after the discharge of the patient from hospital. 
Coders apply international standards when coding diseases, injuries and procedures. They review 
the section of the patient’s medical record relating to the inpatient episode of care to determine all 
of the clinical codes relevant to the patient’s admission. Coders rely on the documentation in the 
patient chart; they can only code the documented diagnoses, and cannot diagnose from results in a 
chart. 
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Patients with a date of death were excluded from the data set. Queensland Health does not always 
receive notification regarding deaths, so not all death-related data can be assumed to be accurate, 
unless the patient died in hospital. The absence of a date of death in HBCIS does not necessarily 
mean that the patient is not deceased. 
Statistical analysis 
Nominal variables are presented as numbers, while continuous variables are presented as mean with 
ranges in brackets. Nominal and continuous variables were compared by the Fisher's exact test and 
the Mann-Whitney U test, respectively.  Statistical significance was defined at the conventional 5% 
level. All computations were performed using the StatsDirect version 2.7.9 statistical software 
(StatsDirect, Ltd.). 
Results: 
Using the HBCIS and TII tools, 3172 patients with ICD-10AM codes for TSCI/TBI were identified 
between July 2006 and December 2012 (Table 1). The mean age of the patients was 43 years (range 
18-93 years) and the mean LOS was 14 days (range 1-1054 days; Table 1). The majority of TSCI/TBI 
patients were discharged home from the hospital, only 12% (388/3172) being discharged to another 
facility. The number of TSCI/TBI patients hospitalized per month increased from 25 in the period 
2006-2007 to 64 in the period 2012-2013 (Figure 1).  
For those TSCI/TBI patients with a LOS≥ 60days the results show that during the period 2011-2012 a 
minimum number of five patients with TSCI/TBI was recorded (mean LOS=257 days, range=67-905 
days; Table 2), whilst a maximum number of 13 patients with TSCI/TBI was recorded during the 
period 2009-2010 (mean LOS=103 days, range=68-156 days; Table 2). The period 2012-2013 
represented only six calendar months i.e. from July 1st to December 31st 2012 with only five long-stay 
patients with TSCI/TBI being recorded (mean LOS=92 days, range=63-123 days; Table 2). TSCI/TBI 
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patients with LOS<60 days had similar discharge destinations (discharged home 65% (2020/3114), 
discharged to another facility 12% (381/3114); (Table 3) as compared to TSCI/TBI patients with LOS 
≥60 days (discharged home 66% (38/58), discharged to another facility 12% (7/58); (Table2) but 
were younger (mean age=43 years, range 18-93 years; Table 3) compared to TSCI/TBI patients with 
LOS ≥60 days (mean age=60 years, range 31-87 years; Table 2). The difference in age was statistically 
significant (P<0.05). 
In addition, six patients were identified with M61 code (HO/MO) during the period of interest 
between July 2006 and December 2012. Medical records of those six patients with HO/MO were 
hand searched and none were associated with TSCI or TBI. Three patients with HO/MO had motor 
vehicle accidents without TSCI or TBI; one was the case of HO/MO following a burns injury; and two 
cases of HO/MO were diagnosed in patients with carcinoma of the testes and renal cell carcinoma 
(Table 4). 
Discussion: 
The prevalence of clinically significant NHO in TSCI patients has been previously determined to be 
between 10% and 53% (16). In the TBI population the prevalence of NHO has been reported as being 
between 10% and 20% (4, 9), though a very recent audit by Reznik, et al., (2014) at a specialised unit in 
Australia, describes lower figures of approximately 4% and 11% for TBI and TSCI patients, 
respectively (5). Over a six and a half year period more than 3,000 patients with TSCI or TBI were 
admitted to TTH, the tertiary referral hospital providing health-care services for the North 
Queensland population, and none were diagnosed with NHO associated with TSCI/TBI. The finding is 
surprising in regard to the large number of patients identified and the fact that the number of 
TSCI/TBI patients hospitalized per month in TTH more than doubled during the audited period 
between July 2006 and December 2013. There are a number of factors that might contribute to our 
finding of zero percent of NHO prevalence in TSCI/TBI patients admitted to TTH. NHO is usually 
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diagnosed when it becomes clinically significant, i.e. causes pain, interferes with movement and/or 
restricts function (1, 3, 5). The TSCI/TBI patients were identified using the ICD-10-AM coding system; 
however, some important complications of NHO such as pain and decreased mobility are also 
associated with TSCI/TBI itself, suggesting that NHO might remain overlooked due to these overlaps 
with the TSCI/TBI as a primary cause of admission.  Furthermore, NHO typically becomes apparent at 
two month post-injury (1, 3). Only a very small percentage of TTH patients with TSCI/TBI were 
hospitalised for ≥ 60 days (~2%), suggesting that the vast majority of TSCI/TBI patients at discharge 
(~98%) were, in fact, below the post-injury time-point of the NHO peak manifestation. The highest 
incidence of TSCI/TBI has been reported as being in the 15-25 year old age group (19, 20) however our 
data showed that TSCI/TBI patients admitted to TTH were approximately twice as old as typical 
TSCI/TBI patients. NHO has also been reported to be primarily diagnosed within this younger age 
group (2, 5, 16-18) and thus the age-related differences in the NHO incidence cannot be excluded as a 
biasing factor in our results. Finally, our data also show that the majority of TSCI/TBI patients 
admitted to TTH during the audit period were discharged home, with only a small percentage being 
discharged to another health-care facility. It is not known if any of these patients were subsequently 
diagnosed with NHO.  
In a recent study undertaken at specialised units, Reznik, et al., (2014)(5) suggested deep vein 
thrombosis to be the only common risk factor in the development of NHO in both the TSCI and TBI 
populations. Additional risk factors in the TBI population were the length of time the patient was 
intubated, the level of spasticity and the number of associated injuries. In the TSCI population the 
additional risk factors included the completeness of the lesion or the presence of multiple pressure 
ulcers (5), thought to be the major complication of prolonged hospitalization (21). Since the ICD-10-AM 
system does not allow for coding of those additional clinical characteristics, the system may be 
considered fundamentally ineffective as a registering tool for the severe complications associated 
with TSCI/TBI such as NHO. 
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In conclusion, NHO is a relatively common complication of neurological trauma. Taking this fact into 
consideration, our findings of zero percent of NHO prevalence in a large group of TSCI/TBI patients 
admitted to the large tertiary referral hospital suggest that NHO may have been missed; possibly due 
to the TSCI/TBI ICD-10-AM codes not being primarily designed for documentation of the TBI/TSCI 
complications. Recommendations forthcoming from this study include regular screening for NHO, if 
the TSCI/TBI ICD-10-AM codes are being recorded, especially in those patients with prolonged 
hospitalization. If NHO remains undiagnosed it may later prove to be an extremely debilitating 
condition in an already functionally compromised individual. 
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APPENDIX 1 
 
Definitions: 
 
Medical Record Number: Unique identifying 6-digit number allocated to each patient. 
Admit Number: Combination of the patient’s Medical Record Number and the number of their 
inpatient episode, for example 123456-5, where 123456 is the Medical Record Number, and the 
episode is the fifth inpatient episode at the nominated facility for that patient. 
Age: Age of the patient at the time of admission. 
Birth date: Patient’s date of birth as recorded in HBCIS. 
Admit Date: Date of admission to hospital for the current inpatient episode of care. 
Discharge Date: Date of discharge from hospital for current inpatient episode of care. 
Also includes statistical discharges (change in care type, for example from Acute to Maintenance or 
Rehabilitation). 
Discharge Disposition: Describes how the inpatient episode of care was terminated, for example 
discharged to home or usual residence, episode change, died in hospital, transfer to another facility. 
Admit Unit: Doctor Unit under which the patient was admitted to hospital. 
Admit Ward: Hospital Ward to which the patient was admitted. 
Admit Source: Describes how the patient was admitted to hospital, for example 
Emergency Department, outpatient appointment, transfer from another facility, or episode change 
from another inpatient episode of care, for example Acute Care to Rehabilitation. 
Admit Status: Shows whether the patient was admitted as an emergency admission, an elective 
admission, or may not be assigned if the admission is as a result of an episode change. 
Admit Type: Indicates the type of care for which the patient has been admitted, for example, acute, 
maintenance, rehabilitation. 
Discharge Unit: Doctor Unit under which the patient is discharged. 
Discharge Ward: Hospital Ward from which the patient is discharged. 
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Days ICU: Number of days spent in the Intensive Care Unit. 
Length Of Stay (LOS): Number of days spent in hospital. Excludes leave days. 
Diagnosis Code: ICD-10-AM code relevant to the patient’s inpatient episode of care. 
Diagnosis Type: Shows whether the diagnosis is: 
• the principal reason for the patient’s admission to hospital, and present on admission (P), 
• was present upon admission but was not the principal reason for admission (A), 
• was not present on admission, and developed during the inpatient episode of care (C), or unable to 
be determined form the patient’s medical record (U). 
Diagnosis description: Description associated with the ICD-10-AM code. 
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Table 1: Number of patients admitted to a tertiary referral hospital between 2006 and 2013 identified by the ICD-10-AM codes for TSCI/TBI. 
 
Characteristic 
Period 
Overall 
2006-2007 2007-2008 2008-2009 2009-2010 2010-2011 2011-2012 2012-2013 
Total number of patients 298 370 502 553 515 548 386 3172 
Age in years (range) 38 (18-85) 42 (18-86) 41 (18-87) 44 (18-91) 45 (18-92) 45 (18-91) 46 (18-93) 43 (18-93) 
Length of stay in days (range) 13 (1-87) 14 (1-263) 15 (1-1054) 14 (1-156) 14 (1-183) 13 (1-905) 15 (1-123) 14 (1-1054) 
Discharge 
destination 
Home 182 (61%) 238 (64%) 336 (67%) 347 (63%) 367 (71%) 329 (60%) 259 (67%) 2058 (65%) 
Another facility 54 (18%) 63 (17%) 75 (15%) 67 (12%) 45 (9%) 57 (10%) 27 (7%) 388 (12%) 
 
 
Age is defined as the chronological age of the patient in years at the date of admission. Period is defined as the time between 1st July and 30th June of the two 
consecutive calendar years. Period 2012-2013 represents only six calendar months, i.e. from 1st July to 31st December 2012. Nominal variables are presented 
as numbers, while continuous variables are presented as mean (range). 
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Table 2: Characteristics of patients with TSCI/TBI hospitalized for ≥ 60 days. 
 
Characteristic 
Period 
Overall 
2006-2007 2007-2008 2008-2009 2009-2010 2010-2011 2011-2012 2012-2013 
Total number of patients 6 7 10 13 12 5 5 58 
Patients with TBI 6 (100%) 7 (100%) 10 (100%) 11 (85%) 12 (100%) 4 (80%) 5 (100%) 55 (95%) 
Patients with TSCI 0 (0%) 0 (0%) 0 (0%) 2 (15%) 0 (0%) 1 (20%) 0 (0%) 3 (5%) 
Age in years (range) 39 (31-49) 60 (36-82) 64 (47-87) 65 (35-82) 61 (37-85) 67 (39-86) 57 (50-72) 60 (31-87) 
Length of stay in days (range) 68 (60-87) 139 (80-263) 191 (61-1054) 103 (68-156) 120 (61-183) 257 (67-905) 92 (63-123) 135 (60-1054) 
Discharge 
destination 
Home 4 (67%)  5 (71%) 4 (40%) 8 (62%) 9 (75%) 4 (80%) 4 (80%) 38 (66%) 
Another facility 0 (0%) 1 (14%) 3 (30%) 1 (8%) 1 (8%) 1 (20%) 0 (0%) 7 (12%) 
 
 
Age is defined as the chronological age of the patient in years at the date of admission. Period is defined as the time between 1st July and 30th June of the two 
consecutive calendar years. Period 2012-2013 represents only six calendar months, i.e. from 1st July to 31st December 2012. Nominal variables are presented 
as numbers, while continuous variables are presented as mean (range). 
 
 
 
 
 
Prevalence of NHO in non-specialised units 
Page | 16  
 
 
 
Table 3: Characteristics of patients with TSCI/TBI hospitalized for <60 days. 
 
Characteristic Period Overall 
2006-2007 2007-2008 2008-2009 2009-2010 2010-2011 2011-2012 2012-2013 
Total number of patients 292 363 492 540 503 543 381 3114 
Patients with TBI 274 (94%) 316 (87%) 476 (97%) 491 (91%) 488 (97%) 489 (90%) 369 (97%) 2903 (93%) 
Patients with TSCI 18 (6%) 47 (13%) 16 (3%) 49 (9%) 15 (3%) 54 (10%) 12 (3%) 211 (7%) 
Age in years (range) 38 (18-85) *42 (18-86) *41 (18-87) *43 (18-91) *44 (18-92) *44 (18-91) 46 (18-93) *43 (18-93) 
Length of stay in days (range) 11 (1-56) 11 (1-53) 11 (1-57) 12 (1-59) 11 (1-56) 11 (1-58) 14 (1-58) 12 (1-59) 
Discharge 
destination 
Home 178 (61%) 233 (64%) 332 (67%) 339 (63%) 358 (71%) 325 (60%) 255 (67%) 2020 (65%) 
Another facility 54 (18%) 62 (17%) 72 (15%) 66 (12%) 44 (9%) 56 (10%) 27 (7%) 381 (12%) 
 
 
Age is defined as the chronological age of the patient in years at the date of admission. Period is defined as the time between 1st July and 30th June of the two 
consecutive calendar years. Period 2012-2013 represents only six calendar months, i.e. from 1st July to 31st December 2012. Nominal variables are presented 
as numbers, while continuous variables are presented as mean (range). Nominal variables such as discharge destinations and continuous variable such as age 
were compared to those of patients with LOS≥60 days (Table 2) using the Fisher's exact test and the Mann-Whitney U test, respectively. Statistically 
significant differences are marked by the asterisk (*). 
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Table 4: Patients with Heterotopic Ossification/Myositis Ossificans 
 
Patient Clinical characteristics Applicable to TSCI/TBI 
1 Chronic LBP, old MVA 20 years ago with fracture of  pelvis No 
2 MVA with multiple fractures  but no TBI or TSCI No 
3 HO following burns No 
4 Minor TBI, testicular Ca possible cause of HO No 
5 MVA with multiple injuries but no TBI or TSCI No 
6 Soft tissue calcification possibly due to renal cell Ca No 
 
 
LBP, low back pain; MVA, motor vehicle accident; TBI, traumatic brain injury; TSCI, traumatic spinal cord injury; HO, heterotopic ossification; Ca, cancer. 
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Figure 1: Number of TSCI/TBI patients admitted per month to a tertiary referral hospital between 2006 and 2013. Period is defined as the time 
between 1st July and 30th June of the two consecutive calendar years. Period 2012-2013 represents only six calendar months, i.e. from 1st July to 31st 
December 2012. 
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